Across TCGA pan-cancer cohorts, MTND1P9 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MTND1P9 data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MTND1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P9 expression acts as an unfavorable survival marker, although some lineages such as COAD and TGCT show a favorable association.
LUSC, UCEC, and COAD are the cancer types where MTND1P9 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.